SNT Biotech founder and CEO Shital Daftari was featured on NBC 5 Chicago's “Tech Trends,” sharing how at-home screening is helping more women complete cervical cancer screening from home.
In the segment, Daftari discusses the barriers that keep many women from being screened, from clinic visits to pelvic exams, and how at-home HPV self-collection meets members where they are. A simple kit at home replaces a visit that may never happen, and for health plans it becomes a way to reach the members who are hardest to engage and close the cervical cancer screening gap at the source.
Why at-home screening matters
Roughly 25 million women in the United States are behind on or have never had cervical screening, and most cervical cancers occur in people who are unscreened or under-screened. At-home HPV self-collection gives women a private, convenient choice, and gives health plans a proven way to lift completion among underserved populations, processed in SNT Biotech's own accredited laboratory.